Public Company News

LEIFRAS Co., Ltd. Awarded Contract to Manage Community-Based Club Activities at Monbetsu Municipal Junior High Schools in Hokkaido

Supporting the Shift of Club Activity Management from Schools to Local Communities Through the "Monbetsu Model" TOKYO, Jan. 29, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and community engageme...

2026-01-29 22:00 5503

Cheche Group Announces Strategic Cooperation with Volkswagen DSSO and Cardif Airstar Insurance to Build Digital Insurance System with Intelligent Pricing Model

BEIJING, Jan. 29, 2026 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced that Volkswagen (Anhui) Digital Sales and Services Co., Ltd. ("DSSO"), Beijing Cardif Airstar ...

2026-01-29 21:30 13613

XtalPi Convenes Global Experts to Shape the Future of Molecular Glue Drug Discovery: From Serendipity to Precision

* Global thought leaders presented cutting-edge research at the 2026 International Symposium on Molecular Glue Drug Discovery. * XtalPi unveils the AI-driven XGlue™ platform to enable rapid, closed-loop molecular glue drug discovery. * Cross-sector discussions emphasized the need for bridgin...

2026-01-29 21:00 6420

Autozi Signs Cooperation Agreement with the Suizhou Special Purpose Vehicle Chamber of Commerce, Targeting US$2 Billion and Forging Another Major Milestone in the Company's Development History.

BEIJING, Jan. 29, 2026 /PRNewswire/ -- Autozi (Stock ticker: AZI), a leading operator of automotive industry supply chain cloud platforms inChina, signed a strategic cooperation agreement today with the Hubei Suizhou Special Purpose Vehicle (SPV) Chamber of Commerce, which is renowned as the "Cap...

2026-01-29 20:15 8971

Ascletis Announces Positive Topline Results from Its Phase III Open-Label Study of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne

-  Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favorable safety and tolerability in a Phase III open-label study -  The exceptional efficacy of denifanstat (ASC40) observed in the Company's previously reported placebo-controlled Phase III trial couple...

2026-01-29 19:00 10079

CN Energy Group Inc. Announces Entry into Framework Agreement for Proposed Acquisition of Blessing Logistics Ltd.

LISHUI, China, Jan. 29, 2026 /PRNewswire/ -- CN Energy Group Inc. (NASDAQ: CNEY) ("CNEY" or the "Company") today announced that, onJanuary 25, 2026, it entered into a framework agreement (the "Framework Agreement") with the shareholders of Blessing Logistics Ltd. ("Blessing Logistics"), an oil tr...

2026-01-29 18:30 9823

TAL Education Group Announces Unaudited Financial Results for the Third Fiscal Quarter Ended November 30, 2025

BEIJING, Jan. 29, 2026 /PRNewswire/ -- TAL Education Group (NYSE: TAL) ("TAL" or the "Company"), a smart learning solutions provider inChina, today announced its unaudited financial results for the third quarter of fiscal year 2026 ended November 30, 2025. Highlights for the Third Quarter of Fisc...

2026-01-29 17:00 7646

Agoda Launches Agoda Impact Lab at ASEAN Tourism Forum

MANILA, Philippines, Jan. 29, 2026 /PRNewswire/ -- Digital travel platform Agoda has announced the launch of Agoda Impact Lab, a pioneering initiative aimed at unlocking the future of travel and technology in Asia. The Lab, launched at ASEAN Tourism Forum, will serve as a launch pad for innovatio...

2026-01-29 15:06 16259

Blokees Exhibits Multiple Products at Spielwarenmesse 2026

SHANGHAI, Jan. 28, 2026 /PRNewswire/ -- From January 27 to 31, Assembly Character Toys brand Blokees made its debut at Spielwarenmesse 2026, exhibiting its expanding product ecosystem to global players. At one of the world's leading international toy fairs, Blokees highlighted its commitment to ...

2026-01-29 13:26 6779

Infosys and Tennis Australia Bring AI-First Experiences and Accessibility to Australian Open 2026

* Enhancing fan engagement with insights, accessibility, and responsible innovation * Showcasing Rally, an interactive AI mascot, and MatchFeel, a tactile experience for visually impaired audiences MELBOURNE, Australia, Jan. 29, 2026 /PRNewswire/ --Infosys (NSE: INF...

2026-01-29 12:58 7387

Ivonescimab Included in FirstWord Pharma's "The Drugs That Will Shape 2026"

HONG KONG, Jan. 28, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) is pleased to share that the international industry media FirstWord Pharma released its list titled "Spotlight On: The Drugs That Will Shape 2026", providing an in-depth analysis of 20 key drugs poised to define the trajectory of the ...

2026-01-29 12:51 5614

WuXi Biologics and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Development and Manufacturing of Innovative Bispecific Antibody

SHANGHAI, Jan. 28, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), and Sinorda Biomedicine today jointly announced a strategic collaboration for the development and manufacturing of SND006, a novel bispecific ...

2026-01-29 10:39 9048

HD Hyundai Chairman Chung Kisun Holds Talks with Prime Minister Modi to Discuss Bilateral Cooperation

* Chairman Chung Kisun attends high-level roundtable at Prime Minister Modi's invitation * Cooperation spans commercial and naval shipbuilding and port crane projects; joint shipyard development to be pursued * "India is a key pillar of our overseas production diversification strategy, pois...

2026-01-29 10:30 6497

SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family

* Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus Family * Next-generation vaccine leveraging SKYCovione's recombinant protein-based platform and nanoparticle technology * SK bioscience will continue to strengthen a Mid- to Long-Term global vaccine...

2026-01-29 10:10 6946

LG Energy Solution Releases 2025 Financial Results

* LG Energy Solution posts KRW 23.7 trillion in consolidated revenue and KRW 1.3 trillion in operating profit in 2025 * Company aims for a mid-teen to 20 percent year-on-year increase in annual revenue and mid-single-digit percent operating profit margin this year -        Aim for more than 90...

2026-01-29 10:03 7950

LG ELECTRONICS TO UNVEIL NEXT-GENERATION COMPONENT TECHNOLOGIES AT AHR EXPO 2026

New Core Technologies for Compressors and Motors Enhance Performance and Efficiency With Redefined Structure, Movement and Position News Summary: * LG Electronics will showcase next-generation compressor and motor technologies at AHR Expo 2026, highlighting a new design approach that redefine...

2026-01-29 09:00 6944

Corero Network Security Secures Two Tier-1 APAC Telecommunications Wins

SmartWall ONE™ Relied Upon by Tier-1 Operators to Protect High-Capacity Networks and Enable DDoS Protection-as-a-Service LONDON, Jan. 29, 2026 /PRNewswire/ -- Corero Network Security

2026-01-29 08:00 7861

APR Exceeds 6 Million Units in Global Sales of MEDICUBE AGE-R Beauty Devices, Strengthening Leadership in Home Beauty Tech

SEOUL, South Korea, Jan. 29, 2026 /PRNewswire/ -- APR Co., Ltd., a global beauty technology company, announced that cumulative global sales of its beauty device brand, MEDICUBE AGE-R, have surpassed 6 million units, underscoring the company's accelerating scale and competitiveness in the global h...

2026-01-29 08:00 7724

First Patient Dosed in Pivotal Phase 3 Study of TLX591-Px (Illuccix®) for Prostate Cancer Imaging in Japanese Patients

MELBOURNE, Australia, Jan. 29, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient has been dosed in the Phase 3 registration study of TLX591-Px (Illuccix®, Kit for the preparation of68Ga-PSMA-11) for prostate cancer imaging i...

2026-01-29 07:43 7799

SOR's EdgeiQ - First Commercial Pilot Deployment

PERTH, Australia, Jan. 29, 2026 /PRNewswire/ -- Strategic Elements Ltd (ASX: SOR) advises that its wholly owned subsidiary, Stealth Technologies Pty Ltd (Stealth), has received a purchase order from a major global gold producer for the pilot deployment ofEdgeiQ, its production efficiency–focused ...

2026-01-29 07:24 4385